Structura Biotechnology
Unlocking the potential of cryo-EM for drug discovery
Unlocking the potential of cryo-EM for drug discovery
Structura Biotechnology is a Toronto-based scientific software company focused on unlocking the potential of cryo-electron microscopy (cryo-EM) for drug discovery. Their platform, CryoSPARC, is positioned as the leading industry solution for the analysis and processing of cryo-EM data. Founded in 2016, the company has been garnering attention in the field of biotechnology. With no specific details on industries or headquarters available, it is clear that the company's innovative approach to leveraging cryo-EM has potential.
There is no investment information
No recent news or press coverage available for Structura Biotechnology.
We care about your data, and we'd love to use cookies make your experience better.